HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Arnold Selected Research

N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-Valinamide

4/2005Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.
12/2004Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Arnold Research Topics

Disease

27Neoplasms (Cancer)
01/2022 - 08/2002
20Parathyroid Neoplasms (Parathyroid Neoplasm)
03/2021 - 06/2002
10Carcinogenesis
10/2020 - 11/2002
9Primary Hyperparathyroidism
04/2022 - 10/2005
9Hyperparathyroidism
10/2020 - 06/2002
7Adenoma (Adenomas)
03/2021 - 10/2006
7Breast Neoplasms (Breast Cancer)
10/2020 - 11/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 12/2004
4Hypercalcemia (Milk Alkali Syndrome)
10/2015 - 10/2005
3Lung Neoplasms (Lung Cancer)
01/2015 - 05/2009
3Disease Progression
04/2005 - 11/2003
2Parathyroid Diseases (Parathyroid Disorders)
06/2020 - 01/2016
2Chromosomal Instability (Chromosome Stability)
04/2015 - 03/2012
2Aneuploidy (Aneuploid)
04/2015 - 03/2012
2Multiple Endocrine Neoplasia Type 1
10/2013 - 04/2011
2Hyperplasia
07/2011 - 10/2007
2Secondary Hyperparathyroidism
07/2011 - 10/2005
2Hemorrhage
05/2009 - 04/2008
2Exanthema (Rash)
04/2005 - 12/2004
1Ossifying Fibroma
07/2021
1Venous Insufficiency
01/2021
1Insulinoma
10/2017
1Neoplastic Processes
04/2017
1Carcinoma (Carcinomatosis)
01/2016
1Adenocarcinoma
04/2015
1Thrombosis (Thrombus)
01/2015
1Chromosome Aberrations (Chromosome Abnormalities)
03/2012
1Hypertension (High Blood Pressure)
01/2010
1Hand-Foot Syndrome
01/2010
1Hypothyroidism
01/2010
1Hemoptysis
01/2010
1Thrombocytopenia (Thrombopenia)
05/2009
1Neuroblastoma
10/2008
1Pain (Aches)
10/2008
1Metabolic Bone Diseases (Osteopenia)
10/2008
1Cataract (Cataracts)
12/2006
1Intellectual Disability (Idiocy)
12/2006
1hereditary Thrombophilia
12/2006
1Body Weight (Weight, Body)
10/2005
1Chronic Renal Insufficiency
10/2005
1Papillary Thyroid Cancer
06/2005

Drug/Important Bio-Agent (IBA)

17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2002
16Cyclin D1IBA
03/2021 - 11/2002
10Parathyroid Hormone (Parathormone)IBA
04/2022 - 11/2002
6Paclitaxel (Taxol)FDA LinkGeneric
01/2015 - 11/2003
5Proteins (Proteins, Gene)FDA Link
07/2021 - 10/2003
5Carboplatin (JM8)FDA LinkGeneric
01/2015 - 12/2004
4Pharmaceutical PreparationsIBA
10/2017 - 12/2004
4CalciumIBA
10/2015 - 11/2002
3CyclinsIBA
10/2020 - 07/2006
3Phosphotransferases (Kinase)IBA
10/2020 - 04/2008
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019 - 10/2013
2Vitamin DFDA LinkGeneric
11/2016 - 12/2006
2Androgen Receptors (Androgen Receptor)IBA
10/2015 - 06/2005
2Cinacalcet (Sensipar)FDA Link
07/2011 - 10/2005
2Hormones (Hormone)IBA
07/2011 - 11/2002
2cediranib (AZD2171)IBA
01/2010 - 04/2008
2Calcitriol Receptors (Calcitriol Receptor)IBA
12/2006 - 11/2002
2Calcium-Sensing ReceptorsIBA
10/2005 - 11/2002
2N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-ValinamideIBA
04/2005 - 12/2004
2Matrix Metalloproteinase InhibitorsIBA
04/2005 - 12/2004
2Trastuzumab (Herceptin)FDA Link
03/2004 - 11/2003
2Genetic Markers (Genetic Marker)IBA
03/2003 - 08/2002
1Oncogene Proteins (Oncogene Protein)IBA
03/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1Codon (Codons)IBA
06/2020
1RNA (Ribonucleic Acid)IBA
10/2017
1X-linked zinc finger proteinIBA
04/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2015
1Thromboplastin (Tissue Factor)IBA
01/2015
1GemcitabineFDA Link
01/2015
1Sulfhydryl Compounds (Thiols)IBA
01/2015
1Protein Disulfide-IsomerasesIBA
01/2015
1DisulfidesIBA
01/2015
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1CateninsIBA
04/2014
1Threonine (L-Threonine)FDA Link
01/2014
1Arginine (L-Arginine)FDA Link
01/2014
1Glutamine (L-Glutamine)FDA Link
01/2014
1Leucine (L-Leucine)FDA Link
01/2014
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2013
1Phenobarbital (Luminal)FDA Link
03/2012
1Cyclin-Dependent Kinase Inhibitor p27IBA
04/2011
1Warfarin (Coumadin)FDA LinkGeneric
05/2009
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2009
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2009
1Angiogenesis InhibitorsIBA
01/2009
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
01/2009
1Tyrosine (L-Tyrosine)FDA Link
04/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2008
1Mitochondrial DNA (mtDNA)IBA
10/2007
1Fibroblast Growth Factor-23IBA
10/2007
1beta CateninIBA
04/2007
1Untranslated Regions (Untranslated Region)IBA
12/2006
1Messenger RNA (mRNA)IBA
12/2006
1AutoantibodiesIBA
10/2006
1HoloenzymesIBA
07/2006

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2015 - 03/2004
2Therapeutics
04/2015 - 01/2010
1Radiotherapy
10/2008